Abstract
As care providers for pregnant women and their babies, the ultimate goal is always a healthy mother and a healthy baby.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down’s syndrome: an international collaborative study. Genet Med. 2012;14:296–305.
NHS Fetal anomaly screening programme Annual Report. NHS FASP April 2010-March 2011. London: UK National Screening Programmes Directorate, 2011.
Ward P, Soothill P. Fetal anomaly ultrasound scanning: the development of a national screening programme for England. Obstet Gynaecol. 2011;13:211–7.
Khalil A, Mahmoodian N, Kulkarni A, Homfray T, Papageorghiou A, Bhide A, Thilaganathan B. Estimation of detection rates of aneuploidy in high-risk pregnancy using an approach based on nuchal translucency and non-invasive prenatal testing: a cohort study. Fetal Diagn Ther. 2015;38(4):254–61.
Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG. 2000;107:1271–5.
Baer RJ, Flessel MC, Jelliffe-Pawlowski LL, Goldman S, Hudgins L, Hull AD, et al. Detection rates for aneuploidy by first-trimester and sequential screening. Obstet Gynecol. 2015;126:753–9.
Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet Gynecol. 2016;47:45–52.
Anandakumar C, Wong YC, Annapoorna V, Arulkumaran S, Chia D, Bongso A, et al. Amniocentesis and its complications. Aust NZ J Obstet Gynecol. 1992;32:97–9.
Odibo AO, Dicke JM, Gray DL, Oberie B, Stamilio DM, Macones GA, et al. Evaluating the rate and risk factors for fetal loss following CVS. Obstet Gynecol. 2008;112:813–9.
Campbell S. Early prenatal diagnosis of neural tube defects by ultrasound. Clin Obstet Gynecol. 1977;20:351–9.
Chaoui R, Nicolaides KH. From nuchal translucency to intracranial translucency, towards the early detection of spina bifida. Ultrasound Obstet Gynecol. 2010;35(2):133–8.
Donald I, Mac Vicar J, Brown TG. Investigation of abdominal masses by pulsed ultrasound. Lancet. 1958;1:1188–95.
Donald I. Clinical applications of ultrasonic technology in obstetrical and gynecological diagnosis. Br J Obstet Gynecol. 1962;69:1036.
Bencerraf BR, Barss VA, Laboda LA. A sonographic sign for the detection in the second trimester of the fetus with Down’s syndrome. Am J Obstet Gynecol. 1985;151:1078–9.
Nicolaides KH, Azar GB, Byrne D. Nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy. Br Med J. 1992;304:867–9.
Hubbard AM. Ultrafast fetal MRI and prenatal diagnosis. Semin Pediatr Surg. 2003;12:143–53.
Levine D, Fetal MRI. J Matern Fetal Neonatal Med. 2004;15:85–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Brindley, N. (2019). Antenatal Screening/Prenatal Diagnosis. In: Carachi, R., Doss, S. (eds) Clinical Embryology. Springer, Cham. https://doi.org/10.1007/978-3-319-26158-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-26158-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26156-0
Online ISBN: 978-3-319-26158-4
eBook Packages: MedicineMedicine (R0)